Your browser doesn't support javascript.
Individual risk management strategy for SARS-CoV-2 infection: A step toward personalized healthcare.
Tippairote, Torsak; Peana, Massimiliano; Chirumbolo, Salvatore; Bjørklund, Geir.
  • Tippairote T; Nutritional and Environmental Medicine Department, Healing Passion Medical Center, Bangkok, Thailand.
  • Peana M; Department of Chemistry and Pharmacy, University of Sassari, Italy.
  • Chirumbolo S; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy; CONEM Scientific Secretary, Verona, Italy.
  • Bjørklund G; Council for Nutritional and Environmental Medicine (CONEM), Mo i Rana, Norway. Electronic address: bjorklund@conem.org.
Int Immunopharmacol ; 96: 107629, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1188657
ABSTRACT
Lethal or critical COVID-19 occurs most in infected hosts with certain risk factors such as advanced age or pre-existing disease. Host metabolic status significantly affects the clinical presentations of SARS-CoV-2 infection. Individual risk management is thus crucial for preventing severe COVID-19. Such susceptibility is individual, depending on a multitude of factors. Personalized risk assessment requires the inclusive analysis of big health data to stratify individual risk and derive a customized action plan. Personalized medicine requires shifting from the virology aspect per se to the whole individual's consideration, including dietary pattern, nutritional status, supporting lifestyle, co-existing diseases, and environmental factors. In this short communication, we discuss the individual management strategy for SARS-CoV2 infection as a step towards future personalized healthcare.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Precision Medicine / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Int Immunopharmacol Journal subject: Allergy and Immunology / Pharmacology Year: 2021 Document Type: Article Affiliation country: J.intimp.2021.107629

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Precision Medicine / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Int Immunopharmacol Journal subject: Allergy and Immunology / Pharmacology Year: 2021 Document Type: Article Affiliation country: J.intimp.2021.107629